$141 Million is the total value of Rye Brook Capital LLC's 27 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | SIGMA LITHIUM RESOURCES CORP | $0 | – | -368,600 | -100.0% | -1.11% | – | |
| XHB | Exit | SPDR S&P HOMEBUILDERS ETFetf | $0 | – | -23,700 | -100.0% | -1.22% | – |
| XLV | Exit | HEALTH CARE SELECT SECTORetf | $0 | – | -14,450 | -100.0% | -1.23% | – |
| XBI | Exit | SPDR S&P BIOTECH ETFetf | $0 | – | -23,100 | -100.0% | -2.28% | – |
| VCR | Exit | VANGUARD CONSUMER DISCRE ETFetf | $0 | – | -28,350 | -100.0% | -6.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-07-19
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES MSCI JAPAN ETF | 12 | Q3 2023 | 14.8% |
| ISHARES NASDAQ BIOTECHNOLOGY | 12 | Q3 2023 | 7.7% |
| VANGUARD REAL ESTATE ETF | 12 | Q3 2023 | 6.0% |
| EQUITY RESIDENTIAL | 12 | Q3 2023 | 2.3% |
| AVALONBAY COMMUNITIES INC | 12 | Q3 2023 | 2.2% |
| INVESCO QQQ TRUST SERIES 1 | 11 | Q2 2023 | 29.1% |
| VANGUARD FTSE EUROPE ETF | 9 | Q3 2023 | 18.9% |
| VANECK SEMICONDUCTOR ETF | 9 | Q1 2023 | 8.8% |
| BLOOMIN' BRANDS INC | 9 | Q3 2023 | 4.1% |
| TRITON INTERNATIONAL LTD | 9 | Q1 2023 | 3.1% |
View Rye Brook Capital LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-11 |
| 13F-HR | 2024-01-30 |
| 13F-HR | 2023-10-10 |
| 13F-HR | 2023-07-24 |
| 13F-HR | 2023-04-21 |
| 13F-HR | 2023-01-06 |
| 13F-HR | 2022-11-03 |
| 13F-HR | 2022-07-21 |
| 13F-HR | 2022-04-28 |
| 13F-HR | 2022-01-12 |
View Rye Brook Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.